RIGL FY 2021 Earnings — Rigel Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

RIGLRigel Pharmaceuticals, Inc.

$541M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$149M+37.4% YoY

Gross Profit

$148M99.3% margin

Operating Income

-$12M-8.4% margin

Net Income

-$18M-12.0% margin

EPS (Diluted)

$-1.10

Cash Flow

Operating Cash Flow

$6M

Free Cash Flow

$5M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$167M

Total Liabilities

$137M

Stockholders' Equity

$30M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$149M	$109M	+37.4%
Gross Profit	$148M	$108M	+37.5%
Operating Income	-$12M	-$29M	+56.9%
Net Income	-$18M	-$30M	+39.8%